ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Total Liabilities 2013–2025
ImmunityBio, Inc. annual total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- ImmunityBio, Inc. total liabilities as of December 31, 2025: 1.00B, a 14.97% increase year-over-year.
- ImmunityBio, Inc. total liabilities for 2025 were 1.00B, a 14.97% increase from 2024.
- ImmunityBio, Inc. total liabilities for 2024 were 871.1M, a 20.11% decrease from 2023.
- ImmunityBio, Inc. total liabilities for 2023 were 1.09B, a 34.26% increase from 2022.
- ImmunityBio, Inc. total liabilities for 2022 were 812.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ImmunityBio, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,001 |
| 2024 | $871 |
| 2023 | $1,090 |
| 2022 | $812 |
| 2021 | $713 |
| 2020 | $340 |
| 2019 | $22 |
| 2018 | $36 |
| 2017 | $32 |
| 2016 | $24 |
| 2015 | $11 |
| 2014 | $2 |
ImmunityBio, Inc. Total Liabilities — FAQ
ImmunityBio, Inc. (IBRX) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IBRX's total liabilities history?
The chart and table above show ImmunityBio, Inc.'s total liabilities by year and by quarter, including the growth rate.